Peditrace Novum

Peditrace Novum is a medicine authorised by Swissmedic under authorisation number 70333. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 13 March 2026 and the authorisation is limited until 12 March 2031. ATC code B05XA31 places the medicine in the group Blood substitutes and perfusion solutions.

  • Dispensing category B
  • Authorisation number 70333
  • ATC B05XA31
  • Synthetic medicines
Authorisation data
Authorisation number70333
NamePeditrace Novum
Full namePeditrace Novum, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderFresenius Kabi (Schweiz) AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeB05XA31
First authorisation13 March 2026
Authorisation validity12 March 2031
Strengths
No.NameDispensing categoryAuthorisation date
1Peditrace Novum, Konzentrat zur Herstellung einer InfusionslösungB13 March 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
120 x 10 mlAmpulle(n)B05XA3107.01.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Peditrace Novum authorised in Switzerland?

Yes. Peditrace Novum is authorised by Swissmedic under authorisation number 70333, data as of 01 September 2026. The authorisation is limited until 12 March 2031.

Which dispensing category does Peditrace Novum have?

Peditrace Novum is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Peditrace Novum?

The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com